Secondary burn progression decreased by erythropoietin

Tobalem, Mickael; Harder, Yves; Rezaeian, Farid; Wettstein, Reto

doi:10.1097/CCM.0b013e318275cee7

Scientific article

English

Secondary burn progression decreased by erythropoietin

ContributorsTobalem, Mickael; Harder, Yves; Rezaeian, Farid; Wettstein, Reto

Published inCritical care medicine, vol. 41, no. 4, p. 963-971

Publication date2013

Abstract

To investigate whether systemic erythropoietin administration can prevent secondary burn progression in an experimental model and to elucidate the underlying mechanisms.

Keywords

Animals
Burns/drug therapy/pathology/prevention & control
Disease Models, Animal
Disease Progression
Erythropoietin/administration & dosage/pharmacology
Male
Necrosis/prevention & control
Neovascularization, Physiologic/drug effects
Oxidative Stress/drug effects
Prospective Studies
Random Allocation
Rats
Rats, Wistar
Wound Healing/drug effects

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Groupe Pittet Cuenod Brigitte (chirurgie plastique et reconstructive) (96)

Citation (ISO format)

TOBALEM, Mickael et al. Secondary burn progression decreased by erythropoietin. In: Critical care medicine, 2013, vol. 41, n° 4, p. 963–971. doi: 10.1097/CCM.0b013e318275cee7

Article (Published version)

Identifiers

PID : unige:32342
DOI : 10.1097/CCM.0b013e318275cee7
PMID : 23324953

Journal ISSN0090-3493

534views

0downloads

Creation10/10/2013 16:40:00

First validation10/10/2013 16:40:00

Update time14/03/2023 20:44:41

Status update14/03/2023 20:44:41

Last indexation30/10/2024 15:27:19

Archive ouverte UNIGE

Secondary burn progression decreased by erythropoietin

To investigate whether systemic erythropoietin administration can prevent secondary burn progression in an experimental model and to elucidate the underlying mechanisms.

Technical informations